{"data":{"id":"us-ak/as-21.27.951","jurisdiction":"us-ak","citation":"AS 21.27.951","heading":"Patient access to clinician-administered drugs.","body":"(a) An insurer or its pharmacy benefits manager may not\n(1) refuse to authorize, approve, or pay a provider for providing covered clinician-administered drugs and related services to a covered person if the provider has agreed to participate in the insurer's health care insurance policy according to the terms offered by the insurer or its pharmacy benefits manager;\n(2) if the criteria for medical necessity are met, condition, deny, restrict, or refuse to authorize or approve a provider for a clinician-administered drug because the provider obtained the clinician-administered drug from a pharmacy that is not a network pharmacy in the insurer's or its pharmacy benefits manager's network;\n(3) require a pharmacy to dispense a clinician-administered drug directly to a covered person or agent of the insured with the intention that the covered person or the agent of the insured will transport the medication to a provider for administration;\n(4) require or encourage the dispensing of a clinician-administered drug to a covered person in a manner that is inconsistent with the supply chain security controls and chain of distribution set by 21 U.S.C. 360eee — 360eee-4 (Drug Supply Chain Security Act);\n(5) require that a clinician-administered drug be dispensed or administered to a covered person in the residence of the covered person or require use of an infusion site external to the office, department, or clinic of the provider of the covered person; nothing in this paragraph prohibits the insurer or its pharmacy benefits manager, or an agent of the insurer or its pharmacy benefits manager, from offering the use of a home infusion pharmacy or external infusion site.\n(b) If a health insurance policy provides in-network and out-of-network benefits and there is not an in-network health care provider or health care facility within a 50-mile radius of the primary residence of a covered person, the health insurance policy must provide coverage to the covered person for clinician-administered drugs at the minimum in-network benefit level.\n(c) In this section, “clinician-administered drug” means a drug, other than a vaccine, that requires administration by a provider and that the United States Food and Drug Administration or the drug's manufacturer has not approved for self-administration.","path":["Title 21. Insurance.","Chapter 27. Producers, Agents, Administrators, Brokers, Adjusters, and Managers.","Article 9. Pharmacy Benefits Managers."],"source_url":"https://www.akleg.gov/basis/statutes.asp#21.27.951","current_through":"Alaska Statutes 2025 (34th Legislature, 2025-2026)","vintage":"","retrieved_at":"2026-09-02T06:17:40Z","sha256":"86300d73cbb035ffe100194d5688e9ce486015d2ed3a30b8d967188e9a2f6193","source_id":"us-ak","stale":false,"prev":"us-ak/as-21.27.950","next":"us-ak/as-21.27.952"},"notice":"GroundRules: Original legal text. Not legal advice."}